Basic Information
ID: ALA5163579
Type: Functional
Description: Invivo antagonist activity at V2R in Pkd1 knockout mouse model of autosomal dominant polycystic kidney disease assessed as reduction in kidney size at 2 mg/kg, sc administered once daily treatment started from postnatal day 6 to 12 days
Organism: Mus musculus
Activity Charts
Bioactivity
Activity Types for Assay ALA5163579
Activity
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 448.95 | 5.68 | 5.68 |
| 561.13 | 5.61 | 5.61 |
| 589.18 | 6.39 | 6.39 |
| 561.17 | 7.01 | 7.01 |
| 575.15 | 6.00 | 6.00 |
| 588.20 | 5.92 | 5.92 |
| 603.21 | 6.78 | 6.78 |
| 567.13 | 7.31 | 7.31 |
| 573.18 | 7.16 | 7.16 |
| 589.14 | 5.53 | 5.53 |